Figure S3 from Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas

Autor: Candelaria Gomez-Manzano, Frederick F. Lang, Ying Yuan, Tiara L. Collier, Marta M. Alonso, Yanhua Yi, Caroline C. Carrillo, Verlene Henry, Xuejun Fan, Juan Fueyo, Teresa T. Nguyen, Dong Ho Shin, Hong Jiang
Rok vydání: 2023
Popis: A, Quantification of the tumor bioluminescence in the mice from the indicated treatment groups. D24-RGDOX: Delta-24-RGDOX. B, Waterfall plots showing tumor burden change from baseline in mice of indicated treatment groups base on the bioluminescence from the tumor. Baseline time point: Day 8 for s.c. tumor, Day 15 for i.c. tumor. Evaluation time point: Day 57 or the last time point before euthanasia.
Databáze: OpenAIRE